Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Tags Novo Nordisk A/S Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
Tags Novo Nordisk A/S Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
Tags Health care industry Obesity Weight loss diets
From CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
Tags Health Investing Eli Lilly and Co
From CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
Tags Eli Lilly and Co US: News Business
From CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
Tags Investing Stock markets LVMH Moet Hennessy Louis Vuitton SE
From CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
Tags Novo Nordisk A/S Business News Social issues
From CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
Tags Business News Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
Tags Breaking News: Markets Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
Tags Markets Europe Markets Investment strategy
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
Tags Health care industry Breaking news Companies
From CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
Tags Investment Strategy U/S/ Markets Markets
From CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
Tags Health care industry Breaking news Viking Therapeutics Inc
From CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
Tags L'Oreal SA Europe Economy Goldman Sachs Group Inc
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Markets WW International Inc Alphabet Inc
From CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
Tags Europe Markets Markets Alphabet Inc
From CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
Tags Market Outlook Warner Bros Discovery Inc Prices
From CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
Tags Weight loss diets Obesity Novo Nordisk A/S
From CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
Tickers CATS DOGS PETS
Tags Pharmaceutical industry regulation AstraZeneca PLC Health care industry
From CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
Tags Health & Science Zealand Pharma A/S Eli Lilly and Co
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
Tags Investing Nestle SA Health & Science
From CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
Tags Zealand Pharma A/S Europe News Pharmaceuticals
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
Tags Health & Science Health Insurance Health insurance
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags AstraZeneca PLC Catalent Inc Pfizer Inc
From CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
Tags Science Eli Lilly and Co US: News
From CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Tags US: News Eli Lilly and Co Health & Science
From CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
Tags Earnings Investment strategy Europe Markets
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Advanced Micro Devices Inc Business United Parcel Service Inc
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Tags Sanofi SA Health care industry Merck & Co Inc
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Amgen Inc Breaking news Companies
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.